Generic Qvar RediHaler Availability

Last updated on Apr 10, 2025.

Qvar RediHaler is a brand name of beclomethasone, approved by the FDA in the following formulation(s):

QVAR REDIHALER (beclomethasone dipropionate - aerosol, metered;inhalation)

• Manufacturer: NORTON WATERFORD
  Approval date: August 3, 2017
  Strength(s): 0.04MG/INH ^[RLD], 0.08MG/INH ^[RLD]

Is there a generic version of Qvar RediHaler available?

No. There is currently no therapeutically equivalent version of Qvar RediHaler available in the United States.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Qvar RediHaler. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: Generic Drug FAQ.

Related patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• Dose counter for inhaler having a bore and shaft arrangement
  Patent 10,022,509
  Issued: July 17, 2018
  Inventor(s): Walsh; Declan et al.
  Assignee(s): Ivax Pharmaceuticals Ireland (Waterford, IE); Norton (Waterford) Limited (Waterford, IE); Teva Pharmaceuticals Ireland (Waterford, IE)
  

  A dose counter for an inhaler, the dose counter having a display tape arranged to be incrementally driven from a tape stock bobbin onto an incremental tape take-up drive shaft, the bobbin having an internal bore supported by and for rotation about a support shaft, at least one of the bore and support shaft having a protrusion which is resiliently biased into frictional engagement with the other of the bore and support shaft with longitudinally extending mutual frictional interaction.

  Patent expiration dates:

  • May 18, 2031
    
    ✓ 
    Drug product
• Dose counters for inhalers, inhalers and methods of assembly thereof
  Patent 10,022,510
  Issued: July 17, 2018
  Inventor(s): Walsh; Declan et al.
  Assignee(s): Ivax Pharmaeuticals Ireland (Waterford, IE); Norton (Waterford) Limited (Waterford, IE); Teva Pharmaceuticals Ireland (Waterford, IE)
  

  A tape system for a dose counter for an inhaler, the tape system having a main elongate tape structure, dosing indicia located on the main elongate tape structure, tape positioning indicia located on the main elongate tape structure, a tape size marker located on the main elongate tape structure indicating a number of dosing indicia on the tape, and priming indicia located on the main elongate tape structure, the priming indicia being located between the dosing indicia and one end of the tape.

  Patent expiration dates:

  • May 18, 2031
    
    ✓ 
    Drug product
• Dose counter for inhaler and method for counting doses
  Patent 10,086,156
  Issued: October 2, 2018
  Inventor(s): Walsh; Declan et al.
  Assignee(s): Ivax Pharmaceuticals Ireland (Waterford, IE); Norton (Waterford) Limited (Waterford, IE); Teva Pharmaceuticals Ireland (Waterford, IE)
  

  A dose counter for a metered dose inhaler includes an incremental counting system for counting doses. The incremental counting system has a main body, an actuator arranged to be driven in response to canister motion and to drive an incremental output member in response to canister motion. The actuator and incremental output member are configured to have predetermined canister fire and count configurations in a canister fire sequence. The canister fire configuration is determined by a position of the actuator relative to a datum at which the canister fires medicament and the count configuration is determined by a position of the actuator relative to the datum at which the incremental count system makes an incremental count. The actuator is arranged to reach a position in the count configuration at or after a position in the canister fire configuration.

  Patent expiration dates:

  • May 18, 2031
    
    ✓ 
    Drug product
• Dose counter for inhaler having an anti-reverse rotation actuator
  Patent 10,561,808
  Issued: February 18, 2020
  Inventor(s): Walsh; Declan et al.
  Assignee(s): IVAX PHARMACEUTICALS IRELAND (Waterford, IE); NORTON (WATERFORD) LIMITED (Waterford, IE); TEVA PHARMACEUTICALS IRELAND (Waterford, IE)
  

  A dose counter for an inhaler includes a counter display arranged to indicate dosage information, and a drive system arranged to move the counter display incrementally in a first direction from a first station to a second station in response to actuation input. A regulator is provided which is arranged to act upon the counter display at the first station to regulate motion of the counter display at the first station to incremental movements.

  Patent expiration dates:

  • January 1, 2032
    
    ✓ 
    Drug product
    ✓ 
    Sponsor has requested patent be delisted
• Dose counter for inhaler having an anti-reverse rotation actuator
  Patent 10,695,512
  Issued: June 30, 2020
  Inventor(s): Walsh; Declan et al.
  Assignee(s): Ivax Pharmaceuticals Ireland (Waterford, IE); Norton (Waterford) Limited (Waterford, IE); Teva Pharmaceuticals Ireland (Waterford, IE)
  

  An inhaler includes a main body having a canister housing, a medicament canister retained in a central outlet port of the canister housing, and a dose counter having an actuation member for operation by movement of the medicament canister. The canister housing has an inner wall, and a first inner wall canister support formation extending inwardly from a main surface of the inner wall. The canister housing has a longitudinal axis X which passes through the center of the central outlet port. The first inner wall canister support formation, the actuation member, and the central outlet port lie in a common plane coincident with the longitudinal axis X such that the first inner wall canister support formation protects against unwanted actuation of the dose counter by reducing rocking of the medicament canister relative to the main body of the inhaler.

  Patent expiration dates:

  • May 18, 2031
    
    ✓ 
    Drug product
• Breath actuated inhaler
  Patent 10,792,447
  Issued: October 6, 2020
  Inventor(s): Walsh Declan & Prendergast Paul & Buck Daniel & Kent Trevor & Thompson Niall
  Assignee(s): NORTON (WATERFORD) LIMITED
  

  A breath actuated metered dose inhaler may include a canister fire system configured to fire a medicament containing canister in response to patient inhalation. The canister fire system may include a pneumatic force holding unit and having a rest configuration in which a metering valve of the canister is in a refill configuration; a prepared configuration in which a canister actuation force is retained by the pneumatic force holding unit and the canister fire system is actuatable by patient inhalation induced airflow; and a fire configuration in which the metering valve is in a dose delivery position. When in the prepared configuration, the force retained by the so pneumatic force holding unit may be reduced by less than about 6% over a period of 5 minutes, preferably less than about 3% over a period of 5 minutes.

  Patent expiration dates:

  • January 25, 2039
    
    ✓ 
    Drug product
• Inhalers and related methods
  Patent 11,395,888
  Issued: July 26, 2022
  Inventor(s): Buck; Daniel et al.
  Assignee(s): Norton (Waterford) Limited (Waterford, IE)
  

  An inhaler housing (14) for an inhaler (10) for inhaling inhalable substances, the inhaler having: a body (14) and a dose counter (24) with a return spring (28), wherein a distinct guide surface (162) is provided for guiding the end of the return spring into a recess (152), the distinct guide surface being wider than an entrance mouth (160) of the recess, a dose counter chamber (22) being provided which is separated from a tubular interior space (182) of the inhaler by a barrier (180), the barrier including a stepped upper wall area (184) including at least three steps (186, 188, 190, 192) at different levels, the inhaler having a valve stem block (62) having an inner bore and a valve stem block having a seal (224) in the inner bore with a second diameter which is smaller than a first diameter of the inner bore, the inhaler having a canister (150) being adapted to move during operation between 1 and 4 mm, a drive being arranged to apply a firing force of between 15 N and 60 N of force to the canister at a position of the canister relative to a valve stem (54) at which the canister fires.

  Patent expiration dates:

  • January 26, 2038
    
    ✓ 
    Drug product
• Dose counter for inhaler having an anti-reverse rotation actuator
  Patent 11,395,889
  Issued: July 26, 2022
  Inventor(s): Walsh; Declan et al.
  Assignee(s): Ivax Pharmaceuticals Ireland (Waterford, IE); Norton (Waterford) Limited (Waterford, IE); Teva Pharmaceuticals Ireland (Waterford, IE)
  

  An inhaler includes a main body having a canister housing, a medicament canister retained in a central outlet port of the canister housing, and a dose counter having an actuation member for operation by movement of the medicament canister. The canister housing has an inner wall, and a first inner wall canister support formation extending inwardly from a main surface of the inner wall. The canister housing has a longitudinal axis X which passes through the center of the central outlet port. The first inner wall canister support formation, the actuation member, and the central outlet port lie in a common plane coincident with the longitudinal axis X such that the first inner wall canister support formation protects against unwanted actuation of the dose counter by reducing rocking of the medicament canister relative to the main body of the inhaler.

  Patent expiration dates:

  • May 18, 2031
    
    ✓ 
    Drug product
    ✓ 
    Sponsor has requested patent be delisted
• Inhalers and related methods
  Patent 11,559,637
  Issued: January 24, 2023
  Inventor(s): Buck; Daniel et al.
  Assignee(s): Norton (Waterford) Limited (Waterford, IE)
  

  An inhaler (10) has a main body for accommodating a medicament reservoir (84), a canister fire system for moving a canister (50) to release a dose in response to air flow, a cap housing (12) for enclosing the canister fire system and canister within an interior chamber defined by the main body (14) and a cap housing, wherein a lock system (250) is provided for locking the cap housing on the main body.

  Patent expiration dates:

  • July 21, 2039
    
    ✓ 
    Drug product
• Inhalers and related methods
  Patent 11,583,643
  Issued: February 21, 2023
  Inventor(s): Buck; Daniel et al.
  Assignee(s): Norton (Waterford) Limited (Waterford, IE)
  

  An inhaler (10) for the inhalation of inhalable substances comprise: a canister (50) having an interior reservoir (84) containing pressurised inhalable substances including fluid; a metering valve (52) including a metering chamber (82) and a valve stem (54) defining a communication path between the metering chamber and the interior reservoir, the communication path (86) including an opening (106) configured to permit flow between a transfer space inside the valve stem and the interior reservoir, the interior reservoir being arranged for orientation above the metering chamber whereby gas such as air located within the metering chamber is replaced with liquid from the interior reservoir.

  Patent expiration dates:

  • August 19, 2041
    
    ✓ 
    Drug product
• Inhalers and related methods
  Patent 11,793,953
  Issued: October 24, 2023
  Inventor(s): Buck; Daniel et al.
  Assignee(s): NORTON (WATERFORD) LIMITED (Waterford, IE)
  

  A nasal inhaler for the inhalation of inhalable substances comprise: a canister having an interior reservoir containing pressurised inhalable substances including fluid; a metering valve including a metering chamber and a valve stem defining a communication path between the metering chamber and the interior reservoir, the communication path including an opening configured to permit flow between a transfer space inside the valve stem and the interior reservoir, the interior reservoir being arranged for orientation above the metering chamber whereby gas located within the metering chamber is replaced with liquid from the interior reservoir.

  Patent expiration dates:

  • January 26, 2038
    
    ✓ 
    Drug product
• Inhalers and related methods
  Patent 11,865,247
  Issued: January 9, 2024
  Inventor(s): Buck; Daniel et al.
  Assignee(s): NORTON (WATERFORD) LIMITED (Waterford, IE)
  

  An inhaler housing (14) for an inhaler (10) for inhaling inhalable substances, the inhaler having: a body (14) and a dose counter (24) with a return spring (28), wherein a distinct guide surface (162) is provided for guiding the end of the return spring into a recess (152), the distinct guide surface being wider than an entrance mouth (160) of the recess, a dose counter chamber (22) being provided which is separated from a tubular interior space (182) of the inhaler by a barrier (180), the barrier including a stepped upper wall area (184) including at least three steps (186, 188, 190, 192) at different levels, the inhaler having a valve stem block (62) having an inner bore and a valve stem block having a seal (224) in the inner bore with a second diameter which is smaller than a first diameter of the inner bore, the inhaler having a canister (150) being adapted to move during operation between 1 and 4 mm, a drive being arranged to apply a firing force of between 15N and 60N of force to the canister at a position of the canister relative to a valve stem (54) at which the canister fires.

  Patent expiration dates:

  • January 26, 2038
    
    ✓ 
    Drug product
• Inhalers and related methods
  Patent 11,896,759
  Issued: February 13, 2024
  Inventor(s): Buck; Daniel et al.
  Assignee(s): NORTON (WATERFORD) LIMITED (Waterford, IE)
  

  An inhaler (10) has a main body for accommodating a medicament reservoir (84), a canister fire system for moving a canister (50) to release a dose in response to air flow, a cap housing (12) for enclosing the canister fire system and canister within an interior chamber defined by the main body (14) and a cap housing, wherein a lock system (250) is provided for locking the cap housing on the main body.

  Patent expiration dates:

  • January 26, 2038
    
    ✓ 
    Drug product
• Breath actuated inhaler
  Patent 11,957,832
  Issued: April 16, 2024
  Inventor(s): Walsh; Declan et al.
  Assignee(s): Norton (Waterford) Limited (Waterford, IE)
  

  A breath actuated metered dose inhaler may comprise a canister fire system configured to fire a medicament containing canister in response to patient inhalation. The canister fire system may comprise a pneumatic force holding unit and having a rest configuration in which a metering valve of the canister is in a refill configuration; a prepared configuration in which a canister actuation force is retained by the pneumatic force holding unit and the canister fire system is actuatable by patient inhalation induced airflow; and a fire configuration in which the metering valve is in a dose delivery position. When in the prepared configuration, the force retained by the pneumatic force holding unit may be reduced by less than about 6% over a period of 5 minutes, preferably less than about 3% over a period of 5 minutes.

  Patent expiration dates:

  • May 5, 2041
    
    ✓ 
    Drug product
• Metered-dose inhaler
  Patent 8,132,712
  Issued: March 13, 2012
  Inventor(s): Fenlon Derek
  Assignee(s): Ivax Pharmaceuticals Ireland
  

  A metered dose inhaler dose counter, the counter includes: an actuator; a rotary gear wheel having a plurality of ratchet teeth; a driver for driving the rotary gear in a step-wise fashion in response to displacement of the actuator; a pawl that prevents reverse rotation of the rotary gear; and a display coupled to the rotary gear.

  Patent expiration dates:

  • September 7, 2028
    
    ✓ 
    Drug product
    ✓ 
    Sponsor has requested patent be delisted
• Inhaler
  Patent 8,931,476
  Issued: January 13, 2015
  Inventor(s): Kaar Simon & Walsh Declan & Fenlon Derek & Buck Dan
  Assignee(s): IVAX Pharmaceuticals Ireland
  

  An inhaler, such as a breath-actuated metered-dose inhaler, for delivering medicament to a patient. The inhaler includes a housing for holding the medicament and having an air inlet and a medicament delivery port which together define an air flow path into which the medicament is dispensed. The air inlet includes an array of elongate apertures formed in the housing, the long sides of adjacent apertures facing each other. Each aperture is provided with a respective different opening in an outer surface of the housing. The opening of each aperture extends in two different planes such that, if at least a part of the opening is covered in one of the two different planes during inhalation by the patient, a void space is created between the cover and the aperture so as to provide an air flow path through the void space to the at least one aperture.

  Patent expiration dates:

  • July 17, 2031
    
    ✓ 
    Drug product

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer